Journal Article (Review Article)

DZNE-2026-00127

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Clinical utility of digital technologies in Parkinson's disease.

Falkenburger, B.Extern* ; Fanciulli, A. ; Pötter-Nerger, M. ; Eimeren, T.Extern* ; Classen, J. ; Höglinger, G.DZNE* ; Redecker, C. ; Winkler, J. ; Klucken, J.

2026
Springer Wien [u.a.]

This record in other databases:    

Please use a persistent id in citations: doi:10.1007/s00702-025-03062-3

Abstract: Digital health technologies (DHTs) are on the verge of changing treatment of Parkinson's disease (PD). This narrative overview article describes DHTs that are already used or in development, focusing on technologies available in Germany and on their clinical utility. Examples include applications that are primarily used by patients, i.e., tools for patient education and empowerment, but also stand-alone interventions improving clinical outcomes including motor and non-motor symptoms. In Germany, these patient-centered DHTs fall under the HTA framework of digital health applications (DIGA). DHT for telemonitoring, in contrast, are designed to support physicians and other healthcare providers and therefore medical devices. DHT are also used increasingly as exploratory endpoints in trials testing neuroprotective treatments.

Keyword(s): Humans (MeSH) ; Parkinson Disease: therapy (MeSH) ; Digital Technology (MeSH) ; Telemedicine (MeSH) ; Germany (MeSH)

---

Contributing Institute(s):

1. Clinical Research (Munich) (Clinical Research (Munich))

Research Program(s):

1. 353 - Clinical and Health Care Research (POF4-353) (POF4-353)

---

Database coverage:
; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; DEAL Springer ; DEAL Springer ; Ebsco Academic Search ; Essential Science Indicators ; IF < 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---